Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q4 2025 Earnings Call Transcript April 15, 2026
Vivos Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.58 EPS, expectations were $-0.45.
Operator: Good day, everyone, and welcome to the Vivos Full Year 2025 Earnings Conference Call. [Operator Instructions] This conference call is being recorded and a replay of today’s call will be available on the Investor Relations section of Vivos’ website and will remain posted there for the...
